Hong Kong-listed biopharmaceutical stocks continued their upward trend in the afternoon, with Biocytogen-B (02315.HK) and Ascletis Pharma (01672.HK) rising by more than 10%, while Ascentage Pharma (066855.HK), Xinwei Medical-B (06609.HK), and WuXi Bi

2026-10-06

Hong Kong-listed biopharmaceutical stocks continued their upward trend in the afternoon, with Biocytogen-B (02315.HK) and Ascletis Pharma (01672.HK) rising by more than 10%, while Ascentage Pharma (066855.HK), Xinwei Medical-B (06609.HK), and WuXi Biologics (02126.HK) also saw significant gains.